# 2019 discharge: European Medicines Agency (EMA)

European Parliament procedure 2020/2157(DEC) (DEC - Discharge procedure, 9th term, committee ENVI). Stage: Procedure completed. 7 committee amendments tabled by 3 Members between 2020-12-16 and 2020-12-16.

## What the amendments focus on

The dossier is the 2019 discharge for the European Medicines Agency (EMA). Amendments address the additional expenditure from the United Kingdom's withdrawal and the Agency's relocation, reports of improprieties, transparency around drugs and vaccines including for COVID-19, the authorisation process for a COVID-19 vaccine, publication of clinical trial and clinical data, handling of requests for access to documents, and application of the clinical trials regulation and information system.

## Most active Members on this file

| Member | Country | Group | Amendments | Markdown |
|---|---|---|---|---|
| Tilly METZ | Luxembourg | Verts/ALE | 6 | https://amendeu.com/md/meps/193292.md |
| Michèle RIVASI | France | Verts/ALE | 6 | https://amendeu.com/md/meps/96743.md |
| Alexandr VONDRA | Czechia | ECR | 1 | https://amendeu.com/md/meps/197537.md |

## Official source documents

- PE660.425: https://www.europarl.europa.eu/doceo/document/ENVI-AM-660425_EN.pdf

Full amendment texts, votes and exports: https://amendeu.com/dossiers/2020-2157-DEC · machine-readable: https://amendeu.com/data/dossiers/2020-2157-DEC.json

---

Source: AmendEU (amendeu.com), built from Parltrack (ODbL), European Parliament Open Data ((c) European Union) and official Parliament documents. Aggregates CC BY 4.0.
Data refreshed: 2026-07-27. Human-readable version: https://amendeu.com/dossiers/2020-2157-DEC
When citing, attribute to "AmendEU (amendeu.com)".